TheEdgeResearch
Home / Stocks / MPXOF

MPX International Corp. (MPXOF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$14,432
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.99
52-Wk Range
0.00001-0.0001
CEO
W. Scott Boyes
Country
CA
Currency
USD

MPX International Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $14,432. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of -369.4%. Its beta of -0.99 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.03
Price / Sales
0.10
Price / Book
0.04
EV / EBITDA
-0.83
Gross margin
62.9%
Operating margin
-202.0%
Net margin
-369.4%
Return on equity
—
Debt / equity
1.07
Current ratio
0.87
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
200
IPO date
2019-03-06
Headquarters
Toronto, ON, CA
About MPX International Corp.

MPX International Corporation operates as a cannabis enterprise, concentrating its efforts on both the medicinal and recreational cannabis sectors across Canada and Switzerland. The company manufactures and supplies a trio of product categories, encompassing raw cannabis flower, various cannabis extracts and related items, and cannabis derivatives, all marketed under its Strain Rec and Salus BioPharma labels. Established in 2015, the firm's corporate headquarters are situated in Toronto, Canada.

Comparable companies

MPX International Corp. is most often compared with the following Healthcare names:

AOLSCNTTQDZCAHCANFLOWLFOZYMFQBIOSDCCQSPLMUSMJ
More research on MPXOF
MPXOF technical analysis MPXOF TheEdge Score Compare against peers
Open full interactive analysis & DCF →